To address this hypothesis, we have analyzed the biologic effects of DUSP26 overexpression in GBM cells and have retrospectively analyzed the prognostic role of DUSP26 using a tissue microarray developed from glioma patients with known histology and characteristics. Here, DUSP26 is linked to central nervous system cancer.